Literature DB >> 1090399

Serum zinc, iron, and copper concentrations during typhoid fever in man: effect of chloramphenicol therapy.

R S Pekarek, R M Kluge, H L DuPont, R W Wannemacher, R B Hornick, K A Bostian, W R Beisel.   

Abstract

In volunteers experimentally infected with Salmonella typhi, serum iron and zinc concentrations became significantly depressed and there was a concomitant rise in serum copper before the onset of overt clinical illness. However, after several days of fever and the initiation of chloramphenicol therapy, serum iron and zinc concentrations significantly increased. Additional studies--in volunteers with typhoid fever treated with chloramphenicol, in a volunteer with typhoid fever receiving cefazolin and gentamicin, and in untreated rhesus monkeys infected with Salmonella typhimurium--provided evidence that the increase in serum iron concentration during the febrile phase was the result of chloramphenicol therapy, whereas the increase in serum zinc concentrations was a disease-related phenomenon. The importance of trace-metal monitoring during infectious disease and chemotherapy is discussed.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1090399

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  3 in total

1.  [Zinc distribution disorder in psoriasis (author's transl)].

Authors:  D Tsambaos; C E Orfanos
Journal:  Arch Dermatol Res       Date:  1977-07-21       Impact factor: 3.017

2.  Electron microscopic x-ray microanalysis of normal and leukemic human lymphocytes.

Authors:  R Yarom; T A Hall; A Polliack
Journal:  Proc Natl Acad Sci U S A       Date:  1976-10       Impact factor: 11.205

3.  Rapidly Escalating Hepcidin and Associated Serum Iron Starvation Are Features of the Acute Response to Typhoid Infection in Humans.

Authors:  Thomas C Darton; Christoph J Blohmke; Eleni Giannoulatou; Claire S Waddington; Claire Jones; Pamela Sturges; Craig Webster; Hal Drakesmith; Andrew J Pollard; Andrew E Armitage
Journal:  PLoS Negl Trop Dis       Date:  2015-09-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.